This is a study using sunitinib for patients ending treatment on a previous sunitinib malate protocol to continue to receive sunitinib. The patient must have been enrolled in one of the following studies: A6181030, A6181064, A6181078, A6181087, A6181094, A6181107, A6181108, A6181110, A6181111, A6181112, A6181113, A6181120, A6181126 and A6181170. Other Pfizer sponsored sunitinib studies may be included in the future.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
223
sunitinib
Emory University, Winship Cancer Institute
Atlanta, Georgia, United States
Investigational Drug Service
Atlanta, Georgia, United States
The Emory Clinic
Atlanta, Georgia, United States
Loyola University Medical Center
Maywood, Illinois, United States
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Number of Participants With Treatment-emergent Adverse Events (AEs) (All Causalities)
Assessment of AEs included type, incidence, severity (graded by the National Cancer Institute \[NCI\] Common Terminology Criteria for Adverse Events \[CTCAE\], Version 3.0, timing, seriousness, and relatedness; and laboratory abnormalities.
Time frame: From first day of treatment on the current study up to 28 days post the last dose of study treatment
Number of Participants With Treatment-emergent AEs (Treatment-Related)
Assessment of AEs included type, incidence, severity (graded by the National Cancer Institute \[NCI\] Common Terminology Criteria for Adverse Events \[CTCAE\], Version 3.0, timing, seriousness, and relatedness; and laboratory abnormalities.
Time frame: From first day of treatment on the current study up to 28 days post the last dose of study treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Siteman Cancer Center
City of Saint Peters, Missouri, United States
Siteman Cancer Center-West County
Creve Coeur, Missouri, United States
Barnes Jewish Hospital
St Louis, Missouri, United States
Washington University School of Medicine, Siteman Cancer Center
St Louis, Missouri, United States
Comprehensive Cancer Center of Nevada
Las Vegas, Nevada, United States
...and 103 more locations